ADNP

Chr 20AD

activity dependent neuroprotector homeobox

Also known as: ADNP1, HVDAS, MRD28

This gene encodes a transcription factor containing homeobox and zinc finger domains that is upregulated by vasoactive intestinal peptide and modulates p53 activity to promote cell viability. Mutations cause Helsmoortel-van der Aa syndrome through an autosomal dominant inheritance pattern, predominantly through loss-of-function mechanisms. The gene shows extreme intolerance to loss-of-function variants, consistent with haploinsufficiency as the primary pathogenic mechanism.

OMIMResearchSummary from RefSeq, OMIM, UniProt, Mechanism
LOFmechanismADLOEUF 0.121 OMIM phenotype
Clinical SummaryADNP
🧬
Gene-Disease Validity (ClinGen)
ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
💊
Clinical Trials
2 active or recruiting trials — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint
0.12LOEUF
pLI 1.000
Z-score 5.61
OE 0.03 (0.010.12)
Highly constrained

Among the most LoF-intolerant genes (~top 3%)

Missense Constraint
2.07Z-score
OE missense 0.76 (0.700.82)
439 obs / 579.4 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios
LoF OE0.03 (0.010.12)
00.351.4
Missense OE0.76 (0.700.82)
00.61.4
Synonymous OE1.34
01.21.6
LoF obs/exp: 1 / 38.7Missense obs/exp: 439 / 579.4Syn Z: -3.92
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveADNP-related neurodevelopmental disorder (Helsmoortel-Van der Aa Syndrome)LOFAD
DN
0.19100th %ile
GOF
0.1799th %ile
LOF
0.85top 5%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to loss-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFprediction above median · 1 literature citation · LOEUF 0.12
DN1 literature citation

Literature Evidence

DNHelsmoortel et al. (2014) noted that mutations in other SWI/SNF components of the BAF complex, such as SMARCB1 (601607) and ARID1B (614556), have been identified in patients with intellectual disability, and hypothesized that the ADNP mutations cause a dominant-negative effect on the recruitment of PMID:24531329
LOFHere, we extended the ADNP syndrome phenotype describing skin abnormalities in both a patient with ADNP syndrome and an Adnp haploinsufficient mice.PMID:30679581

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

ADNP · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold
Clinical Literature
Open Research Assistant →
Full-Text Mentions
NLP-detected gene mentions in article bodies · via PubTator3
PubTator3
Top 5 full-text resultsSearch PubTator3 ↗